371 related articles for article (PubMed ID: 11268997)
1. Cholangiocarcinoma and the role of radiation and chemotherapy.
Price P
Hepatogastroenterology; 2001; 48(37):51-2. PubMed ID: 11268997
[TBL] [Abstract][Full Text] [Related]
2. Arterial chemotherapy and conformal radiation abolish malignant biliary obstruction.
Guan YS; Qing He ; Ping Li ; Fu YC; Zhao SW
Integr Cancer Ther; 2008 Mar; 7(1):51-3. PubMed ID: 18292595
[TBL] [Abstract][Full Text] [Related]
3. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
Demols A; Maréchal R; Devière J; Van Laethem JL
Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of cholangiocarcinomas: a comprehensive review.
Yalcin S
Hepatogastroenterology; 2004; 51(55):43-50. PubMed ID: 15011829
[TBL] [Abstract][Full Text] [Related]
5. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostics and treatment of cholangiocarcinoma].
Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant therapy for resected extrahepatic cholangiocarcinoma: a review of the literature and future directions.
Anderson C; Kim R
Cancer Treat Rev; 2009 Jun; 35(4):322-7. PubMed ID: 19147294
[TBL] [Abstract][Full Text] [Related]
9. Role of liver transplantation in the treatment of cholangiocarcinoma.
Singal A; Welling TH; Marrero JA
Expert Rev Anticancer Ther; 2009 Apr; 9(4):491-502. PubMed ID: 19374602
[TBL] [Abstract][Full Text] [Related]
10. Eleven-year survivor of unresectable intrahepatic cholangiocarcinoma treated using long-term UFT therapy.
Takemura N; Kokudo N; Imamura H; Takazawa Y; Sano K; Sugawara Y; Nakagawa K; Ohtomo K; Makuuchi M
Hepatogastroenterology; 2008; 55(88):1997-9. PubMed ID: 19260466
[TBL] [Abstract][Full Text] [Related]
11. Locoregional intra-arterial therapies for unresectable intrahepatic cholangiocarcinoma.
Hong K; Geschwind JF
Semin Oncol; 2010 Apr; 37(2):110-7. PubMed ID: 20494703
[TBL] [Abstract][Full Text] [Related]
12. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy.
Kelley ST; Bloomston M; Serafini F; Carey LC; Karl RC; Zervos E; Goldin S; Rosemurgy P; Rosemurgy AS
Am Surg; 2004 Sep; 70(9):743-8; discussion 748-9. PubMed ID: 15481288
[TBL] [Abstract][Full Text] [Related]
14. Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma.
Mantel HT; Rosen CB; Heimbach JK; Nyberg SL; Ishitani MB; Andrews JC; McKusick MA; Haddock MG; Alberts SR; Gores GJ
Liver Transpl; 2007 Oct; 13(10):1372-81. PubMed ID: 17427173
[TBL] [Abstract][Full Text] [Related]
15. [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy].
Hayashi H; Beppu T; Ishiko T; Mizumoto T; Masuda T; Okabe K; Baba Y; Okabe H; Takamori H; Kanemitsu K; Hiroto M; Baba H
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1941-3. PubMed ID: 17212153
[TBL] [Abstract][Full Text] [Related]
16. [Palliative therapy of inoperable cholangiocarcinoma].
Gerhardt T; Mey U; Sauerbruch T; Dumoulin FL
Dtsch Med Wochenschr; 2002 Sep; 127(36):1835-9. PubMed ID: 12215930
[No Abstract] [Full Text] [Related]
17. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
[TBL] [Abstract][Full Text] [Related]
18. Effects of the anti-epidermal growth factor receptor antibody cetuximab on cholangiocarcinoma of the liver.
Huang TW; Wang CH; Hsieh CB
Onkologie; 2007 Mar; 30(3):129-31. PubMed ID: 17341899
[TBL] [Abstract][Full Text] [Related]
19. [Regional chemotherapy in experimental cholangiocarcinoma in pigs].
Dufek V; Petrtýl J
Cas Lek Cesk; 1998 Aug; 137(15):464-6. PubMed ID: 9748745
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery.
Todoroki T
Hepatogastroenterology; 2000; 47(33):644-9. PubMed ID: 10919004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
